![](/img/cover-not-exists.png)
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer
Milowsky, Matthew I., Galsky, Matthew D., Morris, Michael J., Crona, Daniel J., George, Daniel J., Dreicer, Robert, Tse, Kin, Petruck, Jesika, Webb, Iain J., Bander, Neil H., Nanus, David M., Scher, HLanguage:
english
Journal:
Urologic Oncology: Seminars and Original Investigations
DOI:
10.1016/j.urolonc.2016.07.005
Date:
October, 2016
File:
PDF, 716 KB
english, 2016